Baveno VII – Renewing consensus in portal hypertension

Roberto De Franchis, Jaime Bosch, Guadalupe Garcia-tsao, Thomas Reiberger, Cristina Ripoll, Juan G. Abraldes, Agustin Albillos, Anna Baiges, Jasmohan Bajaj, Rafael Bañares, Marta Barrufet, Lina Benajiba, Annalisa Berzigotti, Christophe Bureau, Vincenza Calvaruso, Andres Cardenas, Gennaro D’amico, Andrea De Gottardi, Alessandra Dell’era, Angels EscorsellJonathan Fallowfield, Hector Ferral, Sven Francque, Ron Gaba, Juan Carlos Garcia-pagàn, Joan Genescà, Susana Gomes Rodrigues, Jordi Gracia-sancho, Guogong Han, Virginia Hernandez-gea, Jidong Jia, Jean Jacques Kiladjian, Aleksander Krag, Wim Laleman, Vincenzo La Mura, Sabela Lens, Xuefeng Luo, Mattias Mandorfer, Sarwa Darwish Murad, Valerie Paradis, David Patch, Salvatore Piano, Massimo Pinzani, Aurelie Plessier, Massimo Primignani, Bogdan Procopet, Pierre Emmanuel Rautou, Marika Rudler, Shiv K. Sarin, Filippo Schepis, Marco Senzolo, Vijay Shah, Akash Shukla, Puneeta Tandon, Luis Tellez, Dominique Thabut, Maja Thiele, Jonel Trebicka, Dhiraj Tripathi, Emmanouil Tsochatzis, Laura Turco, Fanny Turon, Dominique Valla, Candid Villanueva, Ian Wanless, Hitoshi Yoshiji

Research output: Contribution to journalArticlepeer-review

Abstract

To expand on the work of previous meetings, a virtual Baveno VII workshop was organised for October 2021. Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD – defined at the Baveno VI conference), the presence or absence of clinically significant portal hypertension (CSPH) is associated with differing outcomes, including risk of death, and different diagnostic and therapeutic needs. Accordingly, the Baveno VII workshop was entitled “Personalized Care for Portal Hypertension”. The main fields of discussion were the relevance and indications for measuring the hepatic venous pressure gradient as a gold standard, the use of non-invasive tools for the diagnosis of cACLD and CSPH, the impact of aetiological and non-aetiological therapies on the course of cirrhosis, the prevention of the first episode of decompensation, the management of an acute bleeding episode, the prevention of further decompensation, as well as the diagnosis and management of splanchnic vein thrombosis and other vascular disorders of the liver. For each of these 9 topics, a thorough review of the medical literature was performed, and a series of consensus statements/recommendations were discussed and agreed upon. A summary of the most important conclusions/recommendations derived from the workshop is reported here. The statements are classified as unchanged, changed, and new in relation to Baveno VI.
Original languageEnglish
Pages (from-to)959-974
Number of pages16
JournalJournal of Hepatology
Volume76
Issue number4
Early online date30 Dec 2021
DOIs
Publication statusPublished - 1 Apr 2022

Fingerprint

Dive into the research topics of 'Baveno VII – Renewing consensus in portal hypertension'. Together they form a unique fingerprint.

Cite this